China Shineway Pharmaceutical Group Limited
CSWYY · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $3,778 | $4,517 | $3,951 | $3,224 |
| % Growth | -16.4% | 14.3% | 22.6% | – |
| Cost of Goods Sold | $946 | $1,122 | $1,012 | $813 |
| Gross Profit | $2,832 | $3,394 | $2,938 | $2,410 |
| % Margin | 75% | 75.1% | 74.4% | 74.8% |
| R&D Expenses | $101 | $110 | $117 | $113 |
| G&A Expenses | $291 | $326 | $280 | $257 |
| SG&A Expenses | $1,889 | $2,308 | $2,107 | $1,763 |
| Sales & Mktg Exp. | $1,597 | $1,982 | $1,819 | $1,500 |
| Other Operating Expenses | $0 | $0 | -$105 | -$83 |
| Operating Expenses | $1,989 | $2,419 | $2,120 | $1,793 |
| Operating Income | $843 | $976 | $714 | $534 |
| % Margin | 22.3% | 21.6% | 18.1% | 16.6% |
| Other Income/Exp. Net | $303 | $265 | $203 | $186 |
| Pre-Tax Income | $1,146 | $1,240 | $917 | $720 |
| Tax Expense | $306 | $271 | $194 | $163 |
| Net Income | $840 | $970 | $723 | $557 |
| % Margin | 22.2% | 21.5% | 18.3% | 17.3% |
| EPS | 444 | 512.2 | 384 | 296 |
| % Growth | -13.3% | 33.4% | 29.7% | – |
| EPS Diluted | 444 | 513.4 | 384 | 296 |
| Weighted Avg Shares Out | 2 | 2 | 2 | 2 |
| Weighted Avg Shares Out Dil | 2 | 2 | 2 | 2 |
| Supplemental Information | – | – | – | – |
| Interest Income | $177 | $95 | $98 | $103 |
| Interest Expense | $6 | $3 | $1 | $1 |
| Depreciation & Amortization | $69 | $177 | $186 | $182 |
| EBITDA | $1,221 | $1,420 | $1,104 | $904 |
| % Margin | 32.3% | 31.4% | 27.9% | 28% |